The investment includes increasing manufacturing and research and development capabilities at its Reedsville, Pennsylvania, ...

The fresh funding will support pivotal trials in progress and commercialization preparations at the two heart-focused ...

Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.

By combining surgical video with other insights, Jegatheeswaran hopes Johnson & Johnson can support better outcomes in ...

Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last ...

The records system is available for U.S. ambulatory providers, pending regulatory approval. Oracle plans to launch in the acute care market next year.

Days into the job, CEO Stephen From said the company no longer expects to begin a clinical trial for its robotic system by ...

Cardiosense has appointed John Martin as chief medical officer. The appointment puts Martin in charge of clinical development and product strategy as the company prepares for commercial launch.

The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid ...

Boston Scientific updates instructions of devices linked to 17 deaths The update covers devices used in procedures to implant the company’s Watchman heart device.

Tandem, Insulet monitoring CMS payment proposal for diabetes tech The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for diabetes devices, if finalized.

Masimo said it has implemented measures that reduced its tariff burden by more than half and resolved a cybersecurity incident that occurred in the spring. On a Tuesday earnings call, Szyman unveiled ...